Skip to the page

Data / Form D filings / Synoligo Biotechnologies, Inc.

Synoligo Biotechnologies, Inc.: Form D filing

Synoligo Biotechnologies, Inc., a biotechnology company in Morrisville, NC, filed a Form D with the SEC in 2022. The latest, on August 30, 2022, reports $7 million sold of a $7 million offering to 1 investor.

Find out what Synoligo Biotechnologies, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
500 PERIMETER PARK DR, Morrisville, NC, 27560
Phone
(707) 347-7168
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
$1,000,001 - $5,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1943776

The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 30, 2022New notice$7,000,000$7,000,000$01Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Xibo LiExecutive Officer, Director

Other biotechnology companies in North Carolina that filed recently

Every Form D from the week of Aug 29, 2022 · All recent filings in North Carolina · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Synoligo Biotechnologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.